Search
for
Sort by
Research 661–690 of 934
- MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia
- Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance
- Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
- Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy.
- Promotion effect of Schisandra nigra on the growth of hair
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- The Basic Science of Radiofrequency-Based Devices
- Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study
- Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
- Serum lipid profile and insulin resistance in women with polycystic ovary syndrome (PCOS)
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age
- Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study
- Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- A Rare Case of Steroid Cell Tumor, Not Otherwise Specified (NOS), of the Ovary in a Young Woman
- Confluent and Reticulated Papillomatosis Associated with Polycystic Ovarian Syndrome
- Endocrine abnormalities in ring chromosome 11: a case report and review of the literature
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome
- An unusual circulating steroid profile in a virilized postmenopausal woman
- Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome
- Body mass index across development and adolescent hair cortisol: the role of persistence, variability, and timing of exposure